In NAFLD and especially in NASH, short-term administration of rifaximin appears to be safe and effective.

No abstract

Helicobacter pylori infection and diabetes mellitus are two independent common diseases. It is showed that the worsening glycemic and metabolic control increases the rates of Helicobacter pylori infections and Helicobacter pylori is shown as one of the common problems in diabetic patients with complaints of gastrointestinal diseases. In this study, we aimed to investigate the prevalence and eradication rates of Helicobacter pylori in diabetic patients and the relationship of Helicobacter pylori with the risk factors and diabetic complications. In our study, in which we have included 133 patients, we have shown a significant relationship between Helicobacter pylori infections and metabolic syndrome, insulin resistance, inflammations, and diabetic complications.

Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome

Portal vein thrombosis is a relatively rare but well-known complication of cirrhosis that has a prevalence of between 1% and 5.7%. On the contrary, in case of hepatocellular carcinoma (HCC), it is a much more frequent complication. In this paper, we presented three cases that had liver cirrhosis, mass and portal vein thrombosis in liver. We were not able to diagnose the cases through imaging methods, laboratory results or histopathologically, however, they were diagnosed with endoscopic ultrasonography- fine needle aspiration EUS-FNA from portal vein thrombus.

No abstract

A b s t r a c t Introduction: Diabetes mellitus is the most common endocrine disease in the world. A total of 371 million people with diabetes lived in the world in 2012, 4.8 million people lost their lives due to diabetes, and 612-1099 billion dollars are spent on diabetic patients each year. The aim of our study was to investigate the relationship between the number of hospitalized patients, the demographic and anthropometric characteristics, and diabetic complications. Material and methods: Five hundred patients hospitalized with DM diagnosis were included in this study. Patients were divided into three groups according to the number of hospitalizations. The relationship between the number of hospitalizations and risk factors was examined. Parameters were analyzed using linear regression, c 2 test and independent t-test. Results: When the number of hospitalizations was classified, the groups were formed as the patients who were hospitalized once, twice, or three times or more, respectively: 351 (70.2%), 86 (17.2%), and 63 (12.6%). In our study, it was found that patients with three times or more hospitalizations had worse glycemic control, duration of diabetes, and rate of taking insulin treatment, which was found to be significantly high (p < 0.05), the number of non-smokers was significantly low (p < 0.05), the quitting rate was significantly high (p < 0.05), nephropathy, retinopathy, and cerebrovascular events and cardiovascular diseases were significantly high (p < 0.05) compared to one and two hospitalizations. Conclusions: In our study, it was found that glycemic control and diabetic complications were important determinants in the control of diabetes-related hospitalizations; and well-controlled diabetes was found to reduce the number of hospital admissions of patients with diabetes in Turkey. There are no financial data; however, in this context, it can be envisaged that it will have a lowering effect on the cost per patient.

Background and Objectives: Although there are many studies that investigate the relationship between duodenogastric reflux (DGR) and Helicobacter pylori in adult patients, the reported data are contradictory. In addition, there are very few studies in the literature investigating the relationship between DGR and H. pylori in the pediatric age group. In the present study, we investigated the effect of primary DGR on H. pylori and gastritis. Materials and Methods: A total of 361 patients who were referred to the clinic of our hospital with dyspeptic complaints who had an upper gastrointestinal system endoscopy and a gastric biopsy were included in the study. Results: DGR was detected in 45 cases, and 316 cases that did not have DGR were considered as the control group. Comparisons were made between the DGR cases and the control group in terms of risk factors (age, gender), the presence and density of H. pylori, and the presence and severity of gastritis. The average age of the patients who were included in the study was 11.6 ± 4.6 years. A total of 128 (36%) of the cases were male and 233 (64%) were female. DGR was present in 45 (13%) of the cases. The average age of the patients with DGR was 13.9 ± 3.1 years, the average age of the control group was 11.3 ± 4.7, and there were statistically significant differences (p < 0.001). No significant differences were detected in terms of gender between DGR and the control group (p > 0.05). H. pylori (+) was detected in 29 (64%) of patients with DGR, and in 202 (64%) of the control group. No significant differences were detected between H. pylori prevalence (p = 0.947). Gastritis was detected in 37 (82%) of the patients with DGR, and in 245 (77%) of the control group (p = 0.476). No significant differences were detected between the presence and density of H. pylori, gastritis presence, severity and DGR (p > 0.05). Conclusions: The ages of patients with DGR were significantly higher than in the control group, and advanced age was shown to be a risk factor for primary DGR. It was found that the presence of DGR has no effect on the presence and severity of H. pylori. Given this situation, we consider it is important to eradicate H. pylori infection, especially in the case where H. pylori is present together with DGR.